Jared Shadish
Senior Scientist AstraZeneca
Jared Shadish is a senior scientist in the Protein Engineering and Novel Modalities group at AstraZeneca. His work is focused on developing platforms for the efficient development and screening of multispecific antibodies. Jared received his B.S. in Chemical Engineering at Rensselaer Polytechnic Institute, and his Ph.D. at the University of Washington where he developed techniques to enable the spatiotemporal control of protein presentation in biomaterials. Prior to working at AstraZeneca, Jared was a Postdoc at the National Institutes of Health where he studied the biophysical mechanisms of amyloid formation.
Seminars
Tuesday 15th September 2026
Modular Generation of Multispecific Antibodies Using Protein Trans-Splicing
9:00 am
- Protein trans-splicing is a novel method for the generation of multispecific antibodies
- Spliced antibodies can be made in a wide array of formats and recapitulate the biophysical and functional properties of conventionally produced molecules
- This technology enables the discovery of binder pairs with unique biology by facilitating the high-throughput production and screening of combinatorial libraries of multispecific antibodies
Tuesday 15th September 2026
Group Roundtable Discussions
10:30 am
- Roundtable discussions are designed to be interactive, deep dives where attendees break into smaller groups to explore a focused topic through candid, peer-led conversation. Each group will exchange experiences, challenges, and practical insights before reconvening to share key takeaways with the wider audience and with the conversation being facilitated by our seminar day leaders.